European Parliament 16 June 2010, Written question E-4286/10 Yannick Jadot (Verts/ALE), Carl Schlyter (Verts/ALE), Christian Engström (Verts/ALE), Sandrine Bélier (Verts/ALE), Karima Delli (Verts/ALE) and Oriol Junqueras Vies (Verts/ALE) to the Commission. Does ACTA undermine delinkage of medicine prices and R & D costs?
Also known as
European Union · · · 16-06-2010
The full text of this document is not available at the source (EUR-Lex). Only the bibliographic record is published there.
Read the full text
This document is published by eur-lex.europa.eu.
Moonlit adds the citation network, article-level links and cross-references, which are available to search for free.
Sign in to Moonlit